161 related articles for article (PubMed ID: 21196243)
1. In vitro generation of immune cells from pluripotent stem cells.
Vandekerckhove B; Vanhee S; Van Coppernolle S; Snauwaert S; Velghe I; Taghon T; Leclercq G; Kerre T; Plum J
Front Biosci (Landmark Ed); 2011 Jan; 16(4):1488-504. PubMed ID: 21196243
[TBL] [Abstract][Full Text] [Related]
2. In vitro and in vivo evidence for the long-term multilineage (myeloid, B, NK, and T) reconstitution capacity of ex vivo expanded human CD34(+) cord blood cells.
Kobari L; Pflumio F; Giarratana M; Li X; Titeux M; Izac B; Leteurtre F; Coulombel L; Douay L
Exp Hematol; 2000 Dec; 28(12):1470-80. PubMed ID: 11146169
[TBL] [Abstract][Full Text] [Related]
3. Cytokine-free directed differentiation of human pluripotent stem cells efficiently produces hemogenic endothelium with lymphoid potential.
Galat Y; Dambaeva S; Elcheva I; Khanolkar A; Beaman K; Iannaccone PM; Galat V
Stem Cell Res Ther; 2017 Mar; 8(1):67. PubMed ID: 28302184
[TBL] [Abstract][Full Text] [Related]
4. Brief report: efficient generation of hematopoietic precursors and progenitors from human pluripotent stem cell lines.
Woods NB; Parker AS; Moraghebi R; Lutz MK; Firth AL; Brennand KJ; Berggren WT; Raya A; Izpisúa Belmonte JC; Gage FH; Verma IM
Stem Cells; 2011 Jul; 29(7):1158-64. PubMed ID: 21544903
[TBL] [Abstract][Full Text] [Related]
5. Generation of T cells from human embryonic stem cell-derived hematopoietic zones.
Timmermans F; Velghe I; Vanwalleghem L; De Smedt M; Van Coppernolle S; Taghon T; Moore HD; Leclercq G; Langerak AW; Kerre T; Plum J; Vandekerckhove B
J Immunol; 2009 Jun; 182(11):6879-88. PubMed ID: 19454684
[TBL] [Abstract][Full Text] [Related]
6. Natural Killer Cells Generated From Human Induced Pluripotent Stem Cells Mature to CD56
Euchner J; Sprissler J; Cathomen T; Fürst D; Schrezenmeier H; Debatin KM; Schwarz K; Felgentreff K
Front Immunol; 2021; 12():640672. PubMed ID: 34017328
[TBL] [Abstract][Full Text] [Related]
7. CD133+ cell selection is an alternative to CD34+ cell selection for ex vivo expansion of hematopoietic stem cells.
Kobari L; Giarratana MC; Pflumio F; Izac B; Coulombel L; Douay L
J Hematother Stem Cell Res; 2001 Apr; 10(2):273-81. PubMed ID: 11359674
[TBL] [Abstract][Full Text] [Related]
8. Efficient and simultaneous generation of hematopoietic and vascular progenitors from human induced pluripotent stem cells.
Park TS; Zimmerlin L; Zambidis ET
Cytometry A; 2013 Jan; 83(1):114-26. PubMed ID: 22736485
[TBL] [Abstract][Full Text] [Related]
9. Derivation and characterization of hematopoietic cells from human embryonic stem cells.
Wang L; Cerdan C; Menendez P; Bhatia M
Methods Mol Biol; 2006; 331():179-200. PubMed ID: 16881518
[TBL] [Abstract][Full Text] [Related]
10. Differences in lymphocyte developmental potential between human embryonic stem cell and umbilical cord blood-derived hematopoietic progenitor cells.
Martin CH; Woll PS; Ni Z; Zúñiga-Pflücker JC; Kaufman DS
Blood; 2008 Oct; 112(7):2730-7. PubMed ID: 18621931
[TBL] [Abstract][Full Text] [Related]
11. Transplantable progenitors of natural killer cells are distinct from those of T and B lymphocytes.
Hackett J; Bosma GC; Bosma MJ; Bennett M; Kumar V
Proc Natl Acad Sci U S A; 1986 May; 83(10):3427-31. PubMed ID: 2871552
[TBL] [Abstract][Full Text] [Related]
12. Do we have a workable clinical protocol for differentiating lympho-hematopoietic stem cells from the source of embryonic stem cells and induced pluripotent stem cells in culture?
Chen U
Scand J Immunol; 2014 Oct; 80(4):247-9. PubMed ID: 25041639
[TBL] [Abstract][Full Text] [Related]
13. Characterization of developmental pathway of natural killer cells from embryonic stem cells in vitro.
Tabatabaei-Zavareh N; Vlasova A; Greenwood CP; Takei F
PLoS One; 2007 Feb; 2(2):e232. PubMed ID: 17311098
[TBL] [Abstract][Full Text] [Related]
14. Human pluripotent stem cells differentiated in fully defined medium generate hematopoietic CD34- and CD34+ progenitors with distinct characteristics.
Chicha L; Feki A; Boni A; Irion O; Hovatta O; Jaconi M
PLoS One; 2011 Feb; 6(2):e14733. PubMed ID: 21364915
[TBL] [Abstract][Full Text] [Related]
15. Targeted Disruption of the β2-Microglobulin Gene Minimizes the Immunogenicity of Human Embryonic Stem Cells.
Wang D; Quan Y; Yan Q; Morales JE; Wetsel RA
Stem Cells Transl Med; 2015 Oct; 4(10):1234-45. PubMed ID: 26285657
[TBL] [Abstract][Full Text] [Related]
16. Clinical-scale derivation of natural killer cells from human pluripotent stem cells for cancer therapy.
Knorr DA; Ni Z; Hermanson D; Hexum MK; Bendzick L; Cooper LJ; Lee DA; Kaufman DS
Stem Cells Transl Med; 2013 Apr; 2(4):274-83. PubMed ID: 23515118
[TBL] [Abstract][Full Text] [Related]
17. Increasing Stem Cell Dose Promotes Posttransplant Immune Reconstitution.
Xu N; Shen S; Dolnikov A
Stem Cells Dev; 2017 Apr; 26(7):461-470. PubMed ID: 27998208
[TBL] [Abstract][Full Text] [Related]
18. T-, B- and NK-lymphoid, but not myeloid cells arise from human CD34(+)CD38(-)CD7(+) common lymphoid progenitors expressing lymphoid-specific genes.
Hoebeke I; De Smedt M; Stolz F; Pike-Overzet K; Staal FJ; Plum J; Leclercq G
Leukemia; 2007 Feb; 21(2):311-9. PubMed ID: 17170726
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of hematopoietic potential generated by transplantation of muscle-derived stem cells in mice.
Farace F; Prestoz L; Badaoui S; Guillier M; Haond C; Opolon P; Thomas JL; Zalc B; Vainchenker W; Turhan AG
Stem Cells Dev; 2004 Feb; 13(1):83-92. PubMed ID: 15068696
[TBL] [Abstract][Full Text] [Related]
20. Hematopoietic and nature killer cell development from human pluripotent stem cells.
Ni Z; Knorr DA; Kaufman DS
Methods Mol Biol; 2013; 1029():33-41. PubMed ID: 23756940
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
